14 December 2018
Sentec has acquired Swisstom, which has developed non-invasive, regional lung function monitoring devices based on Electrical Impedance Tomography (EIT). The focus of Swisstom will remain unchanged under the umbrella of Sentec AG. Both companies believe that the combination of EIT and transcutaneous sensor technologies may further advance patient monitoring in critical care settings.
VISCHER AG advised Sentec, the team was led by Matthias Staehelin (Partner) with Luzius Zumstein (Associate) both Corporate.